Nocion Therapeutics raised $62M in a Series B financing led by Arkin Bio Capital and Monograph Capital to advance the lead program in Cough into later stage development.
Amount Raised
$62 Million
Round Type
Series B
WalthamBiotechnologyHealthcareInvestors
Description
Nocion Therapeutics announced a $62 million Series B funding round to advance its lead program in Cough into later stage development. The proceeds from the financing will be used to evaluate the lead program, Taplucanium Dry Powder for Inhalation, in a Phase 2b study in Chronic Cough patients.
Quick answer
Nocion Therapeutics raised $62 Million in a Series B round, dated March 4, 2024. Investors: Osage University Partners, Mission Bio Capital, Mass General Brigham Ventures, F Prime Capital, Canaan Partners, Monograph Capital and Arkin Bio Capital. Nocion Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Nocion Therapeutics raise?
- Nocion Therapeutics raised $62 Million in a Series B round on March 4, 2024.
- Who invested in Nocion Therapeutics?
- Osage University Partners, Mission Bio Capital, Mass General Brigham Ventures, F Prime Capital, Canaan Partners, Monograph Capital and Arkin Bio Capital are named as investors in this round.
- What does Nocion Therapeutics do?
- Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons.
- Where is Nocion Therapeutics based and how big is it?
- Nocion Therapeutics is based in Waltham, Massachusetts, United States.
- Who are the decision-makers at Nocion Therapeutics?
- Fundz holds 2 contacts at Nocion Therapeutics, including the Director of Pharmaceutical Development and Acting Head of Quality. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Nocion Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Phenomix Sciences raised $5M on April 15, 2024.
- Cage Bio raised $4.8M (Seed) on April 15, 2024.
- RenovoRx raised $11M on April 11, 2024.
- BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
- Enlaza Therapeutics raised $84M on April 5, 2024.
- Corvex Legacy Holdings raised $24M (Seed) on April 2, 2024.
Who to call at Nocion Therapeutics, and when
A new round usually means Nocion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nocion Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nocion Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nocion Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nocion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNocion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.